Trial Profile
Long-term Immune Durability After Vaccination With the Vesicular Stomatitis Virus-vectored Zaire Ebola Candidate Vaccine (VSV-EBOV): a Prospective Observational Cohort Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2023
Price :
$35
*
At a glance
- Drugs RVSV-S-GP/VP40 vaccine (Primary)
- Indications Ebola virus infections
- Focus Pharmacodynamics
- 25 May 2021 Status changed from active, no longer recruiting to completed.
- 10 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2017 Status changed from not yet recruiting to recruiting.